
Saturday, July 03, 2021 9:33:29 AM
Pump by Bezos with some Amazon dollars, fill the gap slowly, repeat, till 2022 imo
my posts are always theory and not financial advice

Liked By
Spread the love. Be the first to like this post!
Recent NAUT News
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 • GlobeNewswire Inc. • 01/26/2023 01:00:00 PM
- Nautilus Biotechnology Expands to San Diego • GlobeNewswire Inc. • 01/26/2023 12:45:00 PM
- Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
- Nautilus Biotechnology Launches “First Access Challenge” • GlobeNewswire Inc. • 11/16/2022 01:00:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/01/2022 08:10:29 PM
- Amended Current Report Filing (8-k/a) • Edgar (US Regulatory) • 11/01/2022 10:10:26 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/01/2022 10:08:15 AM
- Nautilus Biotechnology Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/01/2022 10:05:00 AM
- Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 • GlobeNewswire Inc. • 10/05/2022 12:00:00 PM
- Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit • GlobeNewswire Inc. • 09/23/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 09/19/2022 09:51:02 PM
- Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board • GlobeNewswire Inc. • 09/01/2022 12:00:00 PM
- Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference • GlobeNewswire Inc. • 08/30/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/22/2022 11:41:33 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 08/09/2022 08:23:22 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 08/09/2022 10:08:45 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/08/2022 11:49:38 PM
- Nautilus Biotechnolgy (NAUT) Gets a Hold Rating from Goldman Sachs • TipRanks • 08/03/2022 04:45:09 PM
- Nautilus Biotechnolgy (NAUT) Gets a Hold Rating from Morgan Stanley • TipRanks • 08/03/2022 04:44:51 PM
- Post-effective Amendment to Registration Statement (pos Am) • Edgar (US Regulatory) • 08/02/2022 08:28:47 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 08/02/2022 08:25:46 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/02/2022 08:05:41 PM
- Nautilus Biotechnology Reports Second Quarter 2022 Financial Results • GlobeNewswire Inc. • 08/02/2022 10:48:06 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/02/2022 10:00:58 AM
- Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development • GlobeNewswire Inc. • 08/01/2022 08:05:00 PM
FEATURED 1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM